BCHE and Alzheimer disease: Blocking studies confirmed that [11C]4 specifically binds to the chosen target both ex vivo and in vivo. BChE blocking studies performed on brain tissue slices for both WT and AD animals using compound 4 and ethopropazine hydrochlorides as the blockers showed a decrease in the concentration of radioactivity in the presence of the blocker.